rs35850753
This variant is located in the TP53 gene.
▶GWAS Catalog Trait Associations (8)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (8)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
basal cell carcinoma
central nervous system cancer
high density lipoprotein cholesterol measurement
total lipids in medium HDL measurement
concentration of medium HDL particles measurement
glioblastoma multiforme
phospholipids in medium HDL measurement
neuroblastoma
▶ClinVar annotation
▶Research that mentions this SNP (2)
▶Genetic variants in the liver kinase B1‐AMP‐activated protein kinase pathway genes and pancreatic cancer riskMeta-analysisN=15,418Xinyuan Xu et al.(2019)· Molecular Carcinogenesis
Meta-analysis of genetic variants in LKB1-AMPK pathway genes identifies six novel SNPs associated with pancreatic cancer risk in 15,418 European ancestry participants from PanScan and PanC4 cohorts. The study found that MAP2 rs35075084 (T>deletion), PRKAG2 rs2727572 (C>T) and rs34852782 (A>deletion), TP53 rs9895829 (A>G), and RPTOR rs62068300 (G>A) and rs3751936 (G>C) were significantly associated with increased pancreatic cancer risk (OR=1.24, 95% CI=1.16-1.32 for carriers with 5-6 unfavorable genotypes, P<0.0001). Expression quantitative trait loci analysis revealed these variants influence mRNA expression levels of their corresponding genes.
▶Further Confirmation of Germline Glioma Risk Variant rs78378222 inTP53and Its Implication in Tumor Tissues via Integrative Analysis of TCGA DataAssociationN=6,811Wang Z. et al.(2015)· Human Mutation
This study confirms that rs78378222:A>C, a rare germline variant in the TP53 3' untranslated region, confers strong glioma risk (OR=3.14, p=6.48×10⁻¹¹) in a GWAS of 1,856 cases and 4,955 controls. Integrative analysis of TCGA data revealed that the risk allele C disrupts mRNA termination causing aberrant transcripts (~3 kb longer), while the protective allele A is somatically deleted in glioblastoma tissues, supporting a two-hit mechanism in tumor development.
About TP53
This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
View all TP53 variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…